For overseas-headquartered pharma and life sciences companies, the United States represents the largest and most attractive healthcare market in the world.
It is also one of the most heavily regulated.
Many companies entering the U.S. quickly discover that traditional marketing approaches used elsewhere do not always translate. Activities that seem routine in other markets may trigger regulatory concerns, legal reviews, or compliance challenges in the United States.
As a result, some organizations become so focused on avoiding risk that they struggle to generate awareness, build relationships, or create meaningful commercial opportunities.
The reality is that compliance and growth are not mutually exclusive.
Many successful pharmaceutical, biotechnology, medical technology, contract research, laboratory services, and life sciences companies consistently generate demand in the U.S. while operating within strict regulatory frameworks.
The key is understanding how American healthcare buyers make decisions and designing marketing and sales programs that educate, build trust, and support long purchasing cycles without crossing compliance boundaries.
In this article, we will explore how pharma and life sciences companies can create sustainable demand in the U.S. market while protecting their reputation and maintaining compliance.
In many industries, demand generation focuses on creating awareness and driving quick purchases. Life sciences rarely work that way.
U.S. healthcare purchasing decisions often involve:
Each audience has different priorities, concerns, and decision criteria.
A pharmaceutical company may need to educate healthcare professionals while complying with promotional regulations. A diagnostics company may need to convince hospital systems of clinical value. A contract development and manufacturing organization (CDMO) may need to earn trust from biotech executives evaluating long-term partnerships.
In every case, trust matters more than promotion. Companies that focus on education, credibility, and expertise generally outperform those that rely on aggressive marketing tactics.
One of the most common mistakes we see is assuming that regulatory restrictions mean marketing should be minimized.
This often leads to:
Meanwhile, competitors continue publishing research insights, participating in industry events, hosting webinars, contributing expert commentary, and building relationships across the market.
Compliance should shape marketing strategy. It should not eliminate marketing altogether.
The companies that succeed in the U.S. learn how to communicate effectively within established guidelines rather than avoiding communication entirely.
Before discussing demand generation tactics, it is important to understand the broader compliance environment. Depending on your business model, your organization may need to consider guidance and regulations involving:
The specific requirements vary significantly between pharmaceutical companies, biotechnology companies, medical device manufacturers, diagnostic providers, contract research organizations, laboratory service providers, and CDMOs.
For this reason, every organization should work closely with legal and compliance stakeholders before launching campaigns. However, compliance teams should be viewed as strategic partners, not obstacles. The strongest organizations integrate compliance into the planning process from the beginning.
Education is one of the safest and most effective ways to build demand.
Healthcare professionals, researchers, and procurement teams are constantly searching for information that helps them improve patient outcomes, reduce risk, increase efficiency, understand emerging technologies, evaluate suppliers, and stay informed about industry developments.
Educational content marketing creates opportunities to engage audiences without relying on overt promotional claims.
Examples include:
Reports can help buyers understand regulatory changes, clinical developments, market trends, supply chain risks, and manufacturing challenges. Companies that publish valuable industry insights often become trusted resources within their niche.
Highly technical audiences expect depth. Strong articles may cover research methodologies, manufacturing innovations, validation procedures, quality systems, clinical considerations, and emerging technologies. Technical content demonstrates expertise while supporting organic search visibility.
Webinars remain one of the most effective channels for life sciences demand generation. They allow companies to share expertise, answer questions, engage directly with prospects, and generate qualified leads. When educational rather than promotional, webinars can create substantial value while remaining compliance-friendly.
Trust is the currency of healthcare marketing.
Decision-makers are often evaluating significant risks, including patient safety, product performance, regulatory exposure, operational continuity, and supply chain reliability. As a result, buyers want evidence that a company understands their challenges.
Thought leadership helps establish that credibility. Effective thought leadership may include:
The goal is not self-promotion. The goal is helping the market understand important issues while demonstrating expertise. Companies that consistently contribute valuable insights become more visible, more trusted, and more likely to be included in future purchasing conversations.
Many life sciences companies underestimate how frequently decision-makers begin their buying journey online.
Researchers, clinicians, procurement professionals, and executives often search for technical information, product categories, validation approaches, regulatory guidance, industry benchmarks, and potential partners. If your company is not visible during these searches, you may never enter the consideration set.
A strong search strategy includes:
Content should answer real questions buyers ask — how clinical validation works, best practices for sterile manufacturing, FDA considerations for specific product categories, quality management requirements, and laboratory testing methodologies.
A well-organized resource center can include white papers, guides, webinars, case studies, and technical documentation. These assets support both search visibility and lead generation.
Increasingly, healthcare professionals are using AI tools to research vendors, technologies, and industry topics. Companies that consistently publish authoritative content are more likely to appear in AI-generated recommendations and summaries. This makes content quality more important than ever.
Case studies remain one of the most powerful trust-building assets available. They provide evidence that a company has successfully solved real-world challenges.
Strong case studies typically highlight the challenge, the approach, the implementation, and the outcome. However, life sciences companies must ensure they have appropriate permissions and approvals before publishing customer information.
Many organizations use anonymous case studies, aggregated results, or approved customer success stories. Even when details are limited, demonstrating practical outcomes can significantly influence buying decisions.
Healthcare remains a relationship-driven industry. Industry conferences provide opportunities to build awareness, meet decision-makers, strengthen partnerships, showcase expertise, and generate qualified opportunities.
Many overseas-headquartered companies assume exhibiting is the primary objective. In reality, the most successful organizations often combine speaking engagements, panel participation, educational presentations, executive networking, and strategic meetings.
Thought leadership frequently generates more long-term value than booth traffic alone. The companies that stand out are often those contributing expertise rather than simply promoting products.
Scientific credibility is essential. Healthcare audiences expect evidence.
Content that performs particularly well often includes peer-reviewed research references, clinical data summaries, scientific explainers, technical validation content, and expert interviews.
This type of content serves multiple purposes: it builds trust, supports sales conversations, improves search visibility, assists procurement evaluations, and educates key stakeholders. Organizations that invest in scientific communication often create long-term competitive advantages.
One challenge many overseas companies face is the disconnect between marketing and commercial teams. Marketing may focus on visibility while sales teams focus on immediate opportunities. The result is often frustration on both sides.
Successful organizations align around shared goals such as qualified leads, sales opportunities, target account engagement, pipeline contribution, and revenue influence.
Marketing should support the sales process by creating educational assets, case studies, industry insights, competitive differentiation, and follow-up content.
Demand generation is most effective when marketing and sales operate as a unified growth function. This is why Relationship as a Service (RaaS) can be particularly effective for pharma and life sciences companies building long-term trust in the U.S. market.
One of the biggest misconceptions about U.S. market growth is that demand generation begins when a company is ready to sell. In reality, relationships often begin months or years before a purchase occurs.
This is particularly true in pharmaceuticals, biotechnology, medical devices, clinical research, and laboratory services. Decision-makers often monitor companies long before engaging directly.
Consistent visibility helps create familiarity. Familiarity reduces perceived risk. Reduced risk increases the likelihood of future conversations.
This is why successful companies maintain ongoing communication through LinkedIn, email newsletters, industry content, events, webinars, and thought leadership. Demand generation is not a campaign. It is a long-term trust-building process.
Another common mistake is focusing exclusively on lead volume. Life sciences purchasing cycles are often lengthy and complex. Success should be measured through a broader set of indicators:
Website traffic, search visibility, content engagement, and share of voice.
Webinar attendance, content downloads, email engagement, and event participation.
Qualified opportunities, target account engagement, pipeline creation, and revenue contribution.
A prospect who spends six months engaging with your content may ultimately be far more valuable than dozens of low-quality leads.
The strongest life sciences demand generation programs typically combine:
Many overseas-headquartered pharma and life sciences companies view compliance as a limitation. The most successful companies view it differently.
They recognize that compliance creates discipline. It encourages accuracy, transparency, and credibility. Those qualities are precisely what healthcare buyers value most.
Organizations that consistently educate, inform, and support their audiences often become trusted voices within their industries. That trust ultimately drives awareness, relationships, opportunities, and revenue.
In the U.S. market, demand generation is rarely about making the loudest claims. It is about becoming the most credible source of information in your category.
Companies that achieve that balance can grow their presence, strengthen commercial performance, and build lasting relationships without sacrificing compliance.
If you work in the medtech space, our related article on MedTech U.S. market entry and building credibility while staying compliant offers additional insight.
Beyond Borders Marketing helps overseas-headquartered pharma, life sciences, medical technology, and healthcare companies increase visibility, generate qualified opportunities, and support marketing and sales growth in the United States.
If your organization is looking to strengthen its U.S. presence while navigating the realities of compliance, we can help you build a strategy that balances credibility, visibility, and growth through content marketing, lead generation, and relationship-building programs.
Contact our team to get started.
Cameron Heffernan is founder of Beyond Borders Marketing, helping overseas-headquartered B2B companies build traction, trust, and growth in the U.S. market through strategic marketing, thought leadership, and lead generation programs.
